|
C9ORF6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.092120E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.455830E-01 |
| Normal-vs-Stage2 |
4.148800E-01 |
| Normal-vs-Stage3 |
1.144940E-03 |
| Normal-vs-Stage4 |
2.024200E-02 |
| Stage1-vs-Stage2 |
9.524600E-01 |
| Stage1-vs-Stage3 |
1.434200E-02 |
| Stage1-vs-Stage4 |
1.627230E-01 |
| Stage2-vs-Stage3 |
1.837230E-01 |
| Stage2-vs-Stage4 |
3.306600E-01 |
| Stage3-vs-Stage4 |
7.029600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.518000E-02 |
| Normal-vs-AfricanAmerican |
1.567470E-04 |
| Normal-vs-Asian |
7.704600E-01 |
| Caucasian-vs-AfricanAmerican |
9.679700E-03 |
| Caucasian-vs-Asian |
6.890200E-01 |
| AfricanAmerican-vs-Asian |
1.308960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.142400E-03 |
| Normal-vs-Female |
2.640800E-01 |
| Male-vs-Female |
2.757800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.091220E-01 |
| Normal-vs-Age(41-60Yrs) |
3.343600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.493750E-02 |
| Normal-vs-Age(81-100Yrs) |
4.362800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.936600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.317200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.600200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.830400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.604000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.551200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.164800E-01 |
| Normal-vs-Grade 2 |
4.871600E-01 |
| Normal-vs-Grade 3 |
1.100960E-03 |
| Normal-vs-Grade 4 |
3.856500E-03 |
| Grade 1-vs-Grade 2 |
7.143600E-01 |
| Grade 1-vs-Grade 3 |
3.092400E-02 |
| Grade 1-vs-Grade 4 |
2.136100E-02 |
| Grade 2-vs-Grade 3 |
1.560020E-03 |
| Grade 2-vs-Grade 4 |
5.515200E-03 |
| Grade 3-vs-Grade 4 |
4.369800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.770000E-01 |
| Normal-vs-ccB subtype |
1.151510E-04 |
| ccA subtype-vs-ccB subtype |
4.65109994962631E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.704000E-02 |
| Normal-vs-N1 |
4.740800E-01 |
| N0-vs-N1 |
9.350800E-01 |
|
|
